Reinventing GPCR drug discovery using systems biology

We integrate experimental and computational pharmacology to reveal critical properties of novel GPCR drug candidates.

The InterAx Platform

Compounds
Compounds

Compounds

Arrow left to right
Arrow left to right
Assays

The InterAx Platform

Assays

Time-resolved cellular assays

Arrow double
Arrow double
Systems biology analysis
Systems biology analysis

Systems biology analysis

Arrow split
Arrow split
Clustered Compounds
Clustered Compounds

Clustering

Arrow merge
Arrow merge
In vivo
In vivo

Better prediction of in vivo effects

Compounds

Time-resolved cellular assays

Systems biology analysis

Clustering

Better prediction of in vivo effects

InterAx helps partners to accelerate and optimize hit‑to‑lead identification for GPCRs.

With Support From

Featured News

MAY 2020

MAY 2020

InterAx Biotech AG is pleased to announce that Dr. Kurt Kessler has joined the company as the new CEO
APR 2020

APR 2020

A Spanish-Swiss Liaison to fight COVID-19
APR 2020

APR 2020

InterAx Biotech supporting the COVID-19 initiative SARS-CoV-2/ACE-2 pseudovirus entry blocking assay

Meeting Opportunities

No event found!